BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome

Journal of Affective Disorders

Volumn 194, Issue , 2016, Pages 1-8

  Kang, Hee Ju ^a   Bae, Kyung Yeol ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Hong, Young Joon ^a   Ahn, Youngkeun ^a   Jeong, Myung Ho ^a   Yoon, Jin Sang ^a   Kim, Jae Min ^a  

^a Chonnam National University   (South Korea)

Author keywords

Acute coronary syndrome; BDNF; Depression; Escitalopram; Polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESCITALOPRAM; METHIONINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VALINE; ANTIDEPRESSANT AGENT; CITALOPRAM;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BORDERLINE STATE; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DSM-IV; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY; SOUTH KOREA; STATISTICAL MODEL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ALLELES; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84954420049     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.01.033     Document Type: Article

References (58)

1. Anderson, J.L., Adams, C.D., Antman, E.M., Bridges, C.R., Califf, R.M., Casey, D.E. Jr., Chavey, W.E. 2nd, Fesmire, F.M., Hochman, J.S., Levin, T.N., Lincoff, A.M., Peterson, E.D., Theroux, P., Wenger, N.K., Wright, R.S., Jneid, H., Ettinger, S.M., Ganiats, T.G., Philippides, G.J., Jacobs, A.K., Halperin, J.L., Albert, N.M., Creager, M.A., DeMets, D., Guyton, R.A., Kushner, F.G., Ohman, E.M., Stevenson, W., Yancy, C.W., 2013. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 61, e179-347.
2. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch. Gen. Psychiatry 4 1961 561 571
3. S. Bozzini, P. Gambelli, C. Boiocchi, S. Schirinzi, R. Falcone, P. Buzzi, C. Storti, and C. Falcone Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms Int. J. Mol. Med. 24 2009 813 818
4. A.R. Brunoni, M. Lopes, and F. Freqni A systematic review and meta-analysis of clinical studies on major depression and BDNF level: implication for the role of neuroplasticity in depression Int. J. Neuropsychopharmacol. 11 2008 1169 1180
5. R.M. Carney, K.E. Freedland, and R.C. Veith Depression, the autonomic nervous system, and coronary heart disease Psychosom. Med. 67 2005 S29 S33
6. A. Caspi, A.R. Hariri, A. Holmes, R. Uher, and T.E. Moffitt Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits Am. J. Psychiatry 167 2010 509 527
7. R. Colle, E. Deflesselle, S. Martin, D.J. David, P. Hardy, A. Taranu, B. Falissard, C. Verstuyft, and E. Corruble BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients Pharmacogenomics 16 2015 997 1013
8. Daimon, M., Minamino, T., Hashimoto, K., Komuro, I., 2004. Diagnostic agent for ischemic heart disease risk group. JP-2004-059065, PCT/JP05/03500 (US 2008/0146498 A1).
9. R. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
10. M.F. Egan, M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, E. Zaitsev, B. Gold, D. Goldman, M. Dean, B. Lu, and D.R. Weingerger The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2003 257 269
11. A.J. Eisch, C.A. Bolaños, J. de Wit, R.D. Simonak, C.M. Pudiak, M. Barrot, J. Verhaagen, and E.J. Nestler Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression Biol. Psychiatry 54 2003 994 1005
12. J. Ejiri, N. Inoue, S. Kobayashi, R. Shiraki, K. Otsui, T. Honjo, M. Takahashi, Y. Ohashi, S. Ichikawa, M. Terashima, T. Mori, K. Awano, T. Shinke, J. Shite, K. Hirata, H. Yokozaki, S. Kawashima, and M. Yokoyama Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease Circulation 112 2005 2114 2120
13. R.T. Erasmus The brain and heart: dancing in unison? Clin. Chim. Acta 400 2009 1 2
14. V.E. Golimbet, B.A. Volel, A.V. Dolzhikov, G.I. Korovaitseva, and M.I. Isaeva Association of 5-HTR2A and 5-HTR2C serotonin receptor gene polymorphisms with depression risk in patients with coronary heart disease Bull. Exp. Biol. Med. 156 2014 680 683
15. A. Govindarajan, B.S. Rao, D. Nair, M. Trinh, N. Mawjee, S. Tonegawa, and S. Chattarji Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects Proc. Natl. Acad. Sci. USA 103 2006 13208 13213
16. A.J. Grippo, and A.K. Johnson Biological mechanisms in the relationship between depression and heart disease Neurosci. Biobehav. Rev. 26 2002 941 962
17. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
18. B.H. Hansen, J.A. Hanash, A. Rasmussen, J.F. Hansen, N.L. Andersen, O.W. Nielsen, and M. Birket-Smith Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD) J. Psychosom. Res. 72 2012 11 16
19. K. Hashimoto Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions Psychiatry Clin. Neurosci. 64 2010 590
20. S. Henningsson, J. Borg, J. Lundberg, J. Bah, M. Lindström, E. Ryding, H. Jovanovic, T. Saijo, M. Inoue, I. Rosén, L. Träskman-Bendz, L. Farde, and E. Eriksson Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men Biol. Psychiatry 66 2009 477 485
21. Y.J. Hong, M.H. Jeong, Y. Ahn, and J.C. Kang The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR) Int. J. Cardiol. 163 2013 1 4
22. E.J. Huang, and L.F. Reichardt Neutrophins: roles in neuronal development and function Annu. Rev. Neurosci. 24 2001 677 736
23. H.-J. Kang, S.-Y. Kim, K.-Y. Bae, S.-W. Kim, I.-S. Shin, J.-S. Yoon, and J.-M. Kim Comorbidity of depression with physical disorders: research and clinical implications Chonnam Med. J. 51 2015 8 18
24. H.-J. Kang, R. Stewart, K.-Y. Bae, S.-W. Kim, I.-S. Shin, Y.J. Hong, Y. Ahn, M.H. Jeong, J.-S. Yoon, and J.-M. Kim Predictors of depressive disorder following acute coronary syndrome: results from K-DEPACS and EsDEPACS J. Affect. Disord. 181 2015 1 8
25. K.I. Kaptein, P. de Jonge, R.H. van den Brink, and J. Korf Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis Psychosom. Med. 68 2006 662 668
26. P. Kermani, and B. Hempstead Brain-derived neurotrophic factor: a newly described mediator of angiogenesis Trends Cardiovasc. Med. 17 2007 140 143
27. T. Killip, and J.T. Kimball Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients Am. J. Cardiol. 20 1967 457 464
28. J.-M. Kim, R. Stewart, H.-J. Kang, K.-Y. Bae, S.-W. Kim, I.-S. Shin, Y.J. Hong, Y. Ahn, M.H. Jeong, S.-W. Park, Y.-H. Kim, and J.-S. Yoon Serotonergic genes and depressive disorder in acute coronary syndrome: the Korean depression in ACS (K-DEPACS) study Eur. Neuropsychopharmacol. 25 2015 882 888
29. J.-M. Kim, K.-Y. Bae, B.-O. Jung, H.-J. Kang, S.-Y. Kim, S.-W. Kim, I.-S. Shin, Y.J. Hong, J.H. Kim, H.-Y. Shin, Y. Ahn, J.-K. Kim, M.H. Jeong, and J.-S. Yoon Escitalopram Treatment for Depressive Patients with Acute Coronary Syndrome: A 24 Week Double-blind Placebo-controlled Trial J. Clin. Psychiatry 76 2015 62 68
30. J.-M. Kim, R. Stewart, H.-J. Kang, K.-Y. Bae, S.-W. Kim, I.-S. Shin, Y.J. Hong, Y. Ahn, M.H. Jeong, and J.-S. Yoon BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies Psychoneuroendocrinology 62 2015 159 165
31. J.-M. Kim, K.-Y. Bae, H.-J. Kang, S.-W. Kim, I.-S. Shin, Y.J. Hong, J.H. Kim, H.-Y. Shin, Y. Ahn, J.-K. Kim, M.H. Jeong, and J.-S. Yoon Design and methodology for the Korean observational and escitalopram treatment studies of depression in acute coronary syndrome: K-DEPACS and EsDEPACS Psychiatry Investig. 11 2014 89 94
32. J.-M. Kim, S.-W. Kim, R. Stewart, S.-Y. Kim, I.-S. Shin, M.-H. Park, J.-H. Yoon, J.-S. Lee, S.-W. Park, Y.-H. Kim, and J.-S. Yoon Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer Psychosom. Med. 74 2012 8 15
33. J.-M. Kim, R. Stewart, M.-S. Park, H.-J. Kang, S.-W. Kim, I.-S. Shin, H.-R. Kim, M.-G. Shin, K.-H. Cho, and J.-S. Yoon Associations of BDNF Genotype and Promoter Methylation with Acute and Long-Term Stroke Outcomes East Asian Cohort. Plos. ONE 7 2012 e51280
34. J.-M. Kim, R. Stewart, S.-W. Kim, S.-J. Yang, I.-S. Shin, Y.-H. Kim, and J.-S. Yoon BDNF genotype potentially modifying the association between incident stroke and depression Neurobiol. Aging 29 2008 789 792
35. S.S. Lee, S.J. Lee, J. Gwak, H.J. Jung, H. Thi-Le, I.S. Song, E.Y. Kim, and J.G. Shin Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations Ther. Drug. Monit. 29 2007 455 459
36. Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.A., van Zyl, L.T., Baker, B., Swenson, J.R., Ghatavi, K., Abramson, B.L., Dorian, P., Guertin, M.C., CREATE Investigators, 2007. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297, 367-379.
37. F. Lespérance, N. Frasure-Smith, and M. Talajic Major depression before and after myocardial infarction: its nature and consequences Psychosom. Med. 58 1996 99 110
38. H.S. Lett, J.A. Blumenthal, M.A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M.F. Newman Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment Psychosom. Med. 66 2004 305 315
39. Lichtman, J.H., Froelicher, E.S., Blumenthal, J.A., Carney, R.M., Doering, L.V., Frasure-Smith, N., Freedland, K.E., Jaffe, A.S., Leifheit-Limson, E.C., Sheps, D.S., Vaccarino, V., Wulsin, L., 2014. American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129, 1350-1369.
40. Y.Q. Liu, G.B. Su, C.H. Duan, J.H. Wang, H.M. Liu, N. Feng, Q.X. Wang, X.E. Liu, and J. Zhang Brain-derived neurotrophic factor gene polymorphisms are associated with coronary artery disease-related depression and antidepressant response Mol. Med. Rep. 10 2014 3247 3253
41. L. Manni, V. Nikolova, D. Vyagova, G.N. Chaldakov, and L. Aloe Reduced plasma level of NGF and BDNF in patients with acute coronary syndrome Int. J. Cardiol. 102 2005 169 171
42. E.J. Martens, O.R. Smith, J. Winter, J. Denollet, and S.S. Pedersen Cardiac history, prior depression and personality predict course of depressive symptoms after myocardial infarction Psychol. Med. 39 2008 257 264
43. C. Mathers, T. Boerma, and D.M. Fat The global burden of disease: 2004 update 2008 World Health Organization Geneva
44. J.M. McCaffery, Q.L. Duan, N. Frasure-Smith, A. Barhdadi, F. Lespérance, P. Théroux, G.A. Rouleau, and M.P. Dubé Genetic Predictors of depressive symptoms in cardiac patients Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B 2009 381 388
45. D. Nakatani, H. Sato, Y. Sakata, I. Shiotani, K. Kinjo, H. Mizuno, M. Shimizu, H. Ito, Y. Koretsune, A. Hirayama, and M. Hori Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction Osaka Acute Coronary Insufficiency Study Group Am. Heart J. 150 2005 652 658
46. T.Z. Naqvi, A.M. Rafique, V. Andreas, M. Rahban, J. Mirocha, and S.S. Naqvi Predictors of depressive symptoms post-acute coronary syndrome Gend. Med. 4 2007 339 351
47. T. Niitsu, C. Fabbri, F. Bentini, and A. Serretti Pharmacogenetics in major depression: a comprehensive meta-analysis Prog. Neuropsychopharmacol. Biol. Psychiatry 45 2013 183 194
48. C. Otte, J. McCaffery, S. Ali, and M.A. Whooley Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study Am. J. Psychiatry 164 2007 1379 1384
49. Y. Pei, A.K. Smith, Y. Wang, Y. Pan, J. Yang, Q. Chen, W. Pan, F. Bao, L. Zhao, C. Tie, Y. Wang, J. Wang, W. Zhen, J. Zhou, and X. Ma The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B 2012 560 566
50. M. Polyakova, K. Stuke, K. Schuemberg, K. Mueller, P. Schoenknecht, and M.L. Schroeter BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis J. Affect. Disord. 174 2015 432 440
51. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J. Clin. Psychiatry 59 1998 S22 S33
52. S.J. Schleifer, M.M. Macari-Hinson, D.A. Coyle, W.R. Slater, M. Kahn, R. Gorlin, and H.D. Zucker The nature and course of depression following myocardial infarction Arch. Intern. Med. 149 1989 1785 1789
53. T.A. Spijkerman, R.H. van den Brink, J.H. Jansen, H.J. Crijns, and J. Ormel Who is at risk of post -MI depressive symptoms? J. Psychosom. Res. 58 2005 425 432
54. B.D. Thombs, E.B. Bass, D.E. Ford, K.J. Stewart, K.K. Tsilidis, U. Patel, J.A. Fauerbach, D.E. Bush, and R.C. Ziegelstein Prevalence of depression in survivors of acute myocardial infarction J. Gen. Intern. Med. 21 2006 30 38
55. V. Vaccarino, B.D. Johnson, D.S. Sheps, S.E. Reis, S.F. Kelsey, V. Bittner, T. Rutledge, L.J. Shaw, G. Sopko, and C.N. Bairey Merz. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study National Heart, Lung, and Blood Institute J. Am. Coll. Cardiol. 50 2007 2044 2050
56. J.P. van Melle, P. de Jonge, A.M. Kuyper, A. Honig, A.H. Schene, H.J. Crijns, M.P. van den Berg, D.J. van Veldhuisen, and J. Ormel Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT) MIND-IT investigators Int. J. Cardiol. 109 2006 88 94
57. R. von Kanel Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr. Scand. 110 2004 163 177
58. J.X. Zhou, H.C. Li, X.J. Bai, B.C. Chang, C.J. Li, P. Sun, and L.M. Chen Functional Val66Met polymorphism of Brain derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects Behav. Brain Funct. 9 2013 34